Bayer Agreement | Bullish channel
Nicolas Suiffet June 25, 2020 6:58 PM
Bayer, a pharmaceutical group, announced that it has agreed to pay 10.1 - 10.9 billion dollars to resolve major outstanding Monsanto litigation
Bayer, a pharmaceutical group, announced that it has agreed to pay 10.1 - 10.9 billion dollars to resolve major outstanding Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation. The company said: "The main feature is the U.S. Roundup resolution that will bring closure to approximately 75% of the current Roundup litigation involving approximately 125,000 filed and unfiled claims overall."
From a chartist’s point of view, the stock price is nearing the upper end of a short term bullish channel. The daily Relative Strength Index (RSI, 14) struck against its overbought area at 70% and is posting a consolidation move. The 20/50DMAs are ascending and should play a support role. The configuration is mixed. Investors have to remain cautious as these levels may trigger profit taking. Pullbacks to 65E can occur before prices can resume their up trend. A break above 73.5E would open a path to see 78E. Alternatively, a break below 60E would invalidate the short term bullish bias.
Source: GAIN Capital, TradingView
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.